https://www.selleckchem.com/pr....oducts/seclidemstat.
Furthermore, this newly developed cell model successfully discriminated the cytotoxic potency of different PAs evidenced by their IC40 values. In conclusion, the established HSEC-CYP3A4 cell model can be used as a rapid screening platform for assessing the relative potencies of individual PAs on their target HSECs and for investigating the mechanisms underlying PA-induced hepatic sinusoidal damage.Background and Purpose Patients with severe, progressive multiple sclerosis (MS) have complex physical and psychosocial needs, typically
Like
Comment
Share
